aa |
Amino acid |
alloHSCT |
Allogeneic hematopoietic stem cell transplant |
AML |
Acute myeloid leukemia |
CK-AML |
Complex karyotype AML |
CML |
Chronic myeloid leukemia |
CN |
Cytogenetically normal |
CR |
Complete remission |
Del |
Deletion |
DFS |
Disease-free survival |
EFS |
Event-free survival |
FLT3 |
FMS-like tyrosine kinase 3 |
FLT3L |
FLT3 ligand |
FLT3-mut |
FLT3 mutation |
HSC |
Hematopoietic stem/progenitor cell |
IL-3 |
Interleukin-3 |
Indels |
Small insertions or deletions |
ITD |
Internal tandem duplication |
LI-C |
Leukemia-inducing cells |
LSCs |
Leukemic stem cells |
MDS |
Myelodysplastic syndrome |
MLL-PTD |
MLL-partial tandem duplication |
MRD |
Minimal residual disease |
OS |
Overall survival |
PDGF |
Platelet-derived growth factor |
PR |
Partial remission |
RFS |
Relapse-free survival |
RTK |
Receptor tyrosine kinase |
TK |
Tyrosine kinase |
TKD |
Tyrosine kinase domain |
TKIs |
Tyrosine kinase inhibitors |